Inventor · disambiguated record
Nandita Bose
Also filed as: BOSE NANDITA
12 granted patents·18 pending applications·26 citations·filing 2012–2024
88Inventor score
Top patents by PatentIndex Score
30 records- 0189US10114027B2Beta-glucan assay methodsBIOTHERA INC·Filed 2017·Granted Oct 30, 2018·3 cites·19 claims
- 0286US10111901B2Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentBIOTHERA INC·Filed 2016·Granted Oct 30, 2018·4 cites·19 claims
- 0386US10092646B2Compositions and methods for beta-glucan immunotherapyBIOTHERA INC·Filed 2013·Granted Oct 9, 2018·4 cites·13 claims
- 0484US10111900B2β-glucan methods and compositions that affect the tumor microenvironmentBIOTHERA INC·Filed 2016·Granted Oct 30, 2018·3 cites·20 claims
- 0582US9885726B2β-glucan assay methodsBIOTHERA INC·Filed 2014·Granted Feb 6, 2018·3 cites·20 claims
- 0682US2025009782A1Beta-glucan immunotherapies affecting the immune microenvironmentHIBERCELL INC·Filed 2024·Application pending·0 cites
- 0781US2025114392A1Beta-glucan in combination with anti-cancer agents affecting the tumor micrenvironmentHIBERCELL INC·Filed 2024·Application pending·0 cites
- 0880US11229701B2Methods for identifying beta-glucan binding to immune cellsHIBERCELL INC·Filed 2013·Granted Jan 25, 2022·2 cites·6 claims
- 0980US2024350528A1Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentHIBERCELL INC·Filed 2023·Application pending·0 cites
- 1079US9943607B2Beta-glucan compounds, compositions, and methodsBOSE NANDITA·Filed 2012·Granted Apr 17, 2018·3 cites·22 claims
- 1179US9694070B2Compositions including β-glucans and methods of useGORDEN KEITH B·Filed 2012·Granted Jul 4, 2017·4 cites·31 claims
- 1279US2025114391A1Beta-glucan methods and compositions that affect the tumor microenvironmentHIBERCELL INC·Filed 2024·Application pending·0 cites
- 1376US12390526B2Methods for identifying beta-glucan binding to immune cellsHIBERCELL INC·Filed 2021·Granted Aug 19, 2025·0 cites·9 claims
- 1474US2023172967A1Beta-glucan immunotherapies affecting the immune microenvironmentHIBERCELL INC·Filed 2022·Application pending·0 cites
- 1573US2022117998A1Beta-glucan immunotherapies affecting the immune microenvironmentHIBERCELL INC·Filed 2021·Application pending·0 cites
- 1668US2022047620A1Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentHIBERCELL INC·Filed 2021·Application pending·0 cites
- 1767US2024019444A1Beta glucan immunopharmacodynamicsHIBERCELL INC·Filed 2023·Application pending·0 cites
- 1867US2021283169A1Beta-glucan methods and compositions that affect the tumor microenvironmentHIBERCELL INC·Filed 2021·Application pending·0 cites
- 1966US2018369376A1Compositions and methods for beta-glucan immunotherapyBIOTHERA INC·Filed 2018·Application pending·0 cites
- 2065US2019064179A1Beta-glucan assay methodsBIOTHERA INC·Filed 2018·Application pending·0 cites
- 2163US2019060350A1Beta-glucan methods and compositions that affect the tumor microenvironmentBIOTHERA INC·Filed 2018·Application pending·0 cites
- 2262US2019022129A1Beta-glucan immunotherapies affecting the immune microenvironmentBIOTHERA INC·Filed 2017·Application pending·0 cites
- 2362US2019060351A1Beta-glucan in combination with anti-cancer agents affecting the tumor microenvironmentBIOTHERA INC·Filed 2018·Application pending·0 cites
- 2460US10166289B2Compositions including beta-glucans and method of useBIOTHERA INC·Filed 2017·Granted Jan 1, 2019·0 cites·20 claims
- 2560US2025339426A1Gcn2 modulator for treating cancerHIBERCELL INC·Filed 2023·Application pending·0 cites
- 2656US2018256738A1Beta-glucan compounds, compositions, and methodsBIOTHERA INC·Filed 2018·Application pending·0 cites
- 2752US11815435B2Beta glucan immunopharmacodynamicsHIBERCELL INC·Filed 2018·Granted Nov 14, 2023·0 cites·7 claims
- 2852US10092657B2Opsonized β-glucan preparations and methodsBOSE NANDITA·Filed 2012·Granted Oct 9, 2018·0 cites·9 claims
- 2944US2014228543A1MODIFIED AND DERIVATIZED ß-GLUCAN COMPOUNDS, COMPOSITIONS, AND METHODSBIOTHERA INC·Filed 2012·Application pending·0 cites
- 3042US2021283168A1Beta glucan and cd40 agonist combination immunotherapyHIBERCELL INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nandita Bose files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →